03/14/2024
4:00 PM | PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
7:01 AM | PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2024
5:23 PM | Petersen Greg (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
5:24 PM | Hawkins Richard J (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
5:24 PM | PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
van Es-Johansson An (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
5:25 PM | Lenk Robert P (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
5:25 PM | PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
Sims Andrew John Hugh MacIntyre (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/26/2024
5:26 PM | HEDRICK MARC H (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
5:26 PM | LaFrance Norman D. (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
5:27 PM | Clowes Howard (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
3:22 PM | PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
| Form 424B3 | |
11/20/2023
11:15 PM | PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
| Form EFFECT | |
11/20/2023
6:01 AM | PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/17/2023
6:00 AM | Lenk Robert P (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2023
6:00 AM | Lenk Robert P (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
6:00 AM | Lenk Robert P (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
6:00 AM | Lenk Robert P (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
3:55 PM | PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/15/2023
6:00 AM | Clowes Howard (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
6:00 AM | Petersen Greg (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2023
11:15 PM | PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
| Form EFFECT | |
08/21/2023
5:05 AM | PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
| Form 424B3 | |
08/09/2023
6:55 AM | PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
06/08/2023
6:00 AM | Clowes Howard (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2023
7:09 AM | PLUS THERAPEUTICS, INC. (Filer)
Plus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
6:00 AM | Clowes Howard (Reporting)
PLUS THERAPEUTICS, INC. (Issuer)
Plus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
